---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-201662"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2026-05-01T23:59:59+00:00"
generated_at: "2026-05-15T00:21:01.235682+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AVITA Medical appoints Cary Vance as permanent CEO, Jan Stern Reed as Board Chair

## Summary
- Cary Vance named President and CEO effective April 30, 2026; served as Interim CEO since October 2025.
- Jan Stern Reed appointed Chair of the Board; had been Lead Independent Director since October 2025.
- Vance receives $702k base salary, 80% bonus target, and $3.354M in equity awards subject to stockholder approval.
- Employment agreement: 3-year initial term; severance of 18 months base salary plus COBRA if terminated without cause.

## SEC filing metadata
- accession: 0001193125-26-201662
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2026-05-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/rcel-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-201662
- JSON: https://secwatch.observer/filing/0001193125-26-201662.json
- Plain text: https://secwatch.observer/filing/0001193125-26-201662.txt

## Key facts
- Executive change
  Jan Stern Reed was appointed as Chair of the Board at AVITA Medical, Inc..
  - Action: appointed
  - Role: Chair of the Board
  source text: the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position that she had been serving since October 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm
- Executive change
  Cary Vance was appointed as President and Chief Executive Officer at AVITA Medical, Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: the Board of Directors (the “Board”) of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.